ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,205,416 | -66.5% | 17,800 | -64.6% | 0.14% | -64.3% |
| Q2 2023 | $3,599,971 | +25.1% | 50,300 | +21.3% | 0.39% | +8.7% |
| Q1 2023 | $2,878,502 | +40.3% | 41,471 | +34.0% | 0.36% | +16.3% |
| Q1 2022 | $2,052,000 | +149.9% | 30,939 | +119.4% | 0.31% | +18.1% |
| Q4 2021 | $821,000 | -53.7% | 14,100 | -52.2% | 0.26% | -49.5% |
| Q3 2021 | $1,772,000 | +103.0% | 29,500 | +78.8% | 0.51% | +165.8% |
| Q2 2020 | $873,000 | +233.2% | 16,497 | +181.7% | 0.19% | +238.6% |
| Q1 2020 | $262,000 | -89.9% | 5,856 | -88.7% | 0.06% | -87.1% |
| Q4 2019 | $2,586,000 | +252.8% | 51,856 | +192.0% | 0.44% | +190.8% |
| Q2 2019 | $733,000 | -72.9% | 17,756 | -73.5% | 0.15% | -70.8% |
| Q1 2019 | $2,707,000 | +128.4% | 66,956 | +114.5% | 0.52% | +114.0% |
| Q4 2018 | $1,185,000 | +195.5% | 31,213 | +155.8% | 0.24% | -7.6% |
| Q3 2016 | $401,000 | – | 12,200 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |